Literature DB >> 30578297

Disruption of peroxisome proliferator-activated receptor γ coactivator (PGC)-1α reverts key features of the neoplastic phenotype of glioma cells.

Ines Bruns1,2,3,4, Benedikt Sauer1,2,3,4, Michael C Burger1,2,3,4, Jule Eriksson1,5, Ute Hofmann6,7, Yannick Braun8, Patrick N Harter2,3,4,8, Anna-Luisa Luger1,2,3,4, Michael W Ronellenfitsch9,2,3,4, Joachim P Steinbach10,2,3,4, Johannes Rieger1,11.   

Abstract

The peroxisome proliferator-activated receptor γ coactivator (PGC)-1α is a master regulator of mitochondrial biogenesis and controls metabolism by coordinating transcriptional events. Here, we interrogated whether PGC-1α is involved in tumor growth and the metabolic flexibility of glioblastoma cells. PGC-1α was expressed in a subset of established glioma cell lines and primary glioblastoma cell cultures. Furthermore, a higher PGC-1α expression was associated with an adverse outcome in the TCGA glioblastoma dataset. Suppression of PGC-1α expression by shRNA in the PGC-1α-positive U343MG glioblastoma line suppressed mitochondrial gene expression, reduced mitochondrial membrane potential, and diminished oxygen as well as glucose consumption, and lactate production. Compatible with the known PGC-1α functions in reactive oxygen species (ROS) metabolism, glioblastoma cells deficient in PGC-1α displayed ROS accumulation, had reduced RNA levels of proteins involved in ROS detoxification, and were more susceptible to death induction by H2O2 compared with control cells. PGC-1αsh cells also had impaired proliferation and migration rates in vitro and displayed less stem cell characteristics. Complementary effects were observed in PGC-1α-low LNT-229 cells engineered to overexpress PGC-1α. In an in vivo xenograft experiment, tumors formed by U343MG PGC-1αsh glioblastoma cells grew much slower than control tumors and were less invasive. Interestingly, the PGC-1α knockdown conferred protection against hypoxia-induced cell death, probably as a result of less active anabolic pathways, and this effect was associated with reduced epidermal growth factor expression and mammalian target of rapamycin signaling. In summary, PGC-1α modifies the neoplastic phenotype of glioblastoma cells toward more aggressive behavior and therefore makes PGC-1α a potential target for anti-glioblastoma therapies.
© 2019 Bruns et al.

Entities:  

Keywords:  glioblastoma; hypoxia; peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) (PPARGC1A); reactive oxygen species (ROS); transcription coactivator; tumor metabolism

Mesh:

Substances:

Year:  2018        PMID: 30578297      PMCID: PMC6398126          DOI: 10.1074/jbc.RA118.006993

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  GlioVis data portal for visualization and analysis of brain tumor expression datasets.

Authors:  Robert L Bowman; Qianghu Wang; Angel Carro; Roel G W Verhaak; Massimo Squatrito
Journal:  Neuro Oncol       Date:  2016-11-09       Impact factor: 12.300

2.  PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress.

Authors:  Francisca Vazquez; Ji-Hong Lim; Helen Chim; Kavita Bhalla; Geoff Girnun; Kerry Pierce; Clary B Clish; Scott R Granter; Hans R Widlund; Bruce M Spiegelman; Pere Puigserver
Journal:  Cancer Cell       Date:  2013-02-14       Impact factor: 31.743

3.  Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis.

Authors:  Christina Wanka; Joachim P Steinbach; Johannes Rieger
Journal:  J Biol Chem       Date:  2012-08-10       Impact factor: 5.157

4.  Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF.

Authors:  Rizwan Haq; Jonathan Shoag; Pedro Andreu-Perez; Satoru Yokoyama; Hannah Edelman; Glenn C Rowe; Dennie T Frederick; Aeron D Hurley; Abhinav Nellore; Andrew L Kung; Jennifer A Wargo; Jun S Song; David E Fisher; Zolt Arany; Hans R Widlund
Journal:  Cancer Cell       Date:  2013-03-07       Impact factor: 31.743

5.  Effects of hypoxia-ischemia on GLUT1 and GLUT3 glucose transporters in immature rat brain.

Authors:  S J Vannucci; L B Seaman; R C Vannucci
Journal:  J Cereb Blood Flow Metab       Date:  1996-01       Impact factor: 6.200

6.  Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4.

Authors:  Ruth Scherz-Shouval; Elena Shvets; Ephraim Fass; Hagai Shorer; Lidor Gil; Zvulun Elazar
Journal:  EMBO J       Date:  2007-03-08       Impact factor: 11.598

Review 7.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

8.  Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma.

Authors:  Xing-Gang Mao; Chao Wang; Dong-Ye Liu; Xiang Zhang; Liang Wang; Ming Yan; Wei Zhang; Jun Zhu; Zi-Chao Li; Chen Mi; Jing-Yang Tian; Guang-Dong Hou; Si-Yu Miao; Zi-Xuan Song; Jin-Cheng Li; Xiao-Yan Xue
Journal:  Oncotarget       Date:  2016-07-26

Review 9.  The role of glucose transporters in brain disease: diabetes and Alzheimer’s Disease.

Authors:  Kaushik Shah; Shanal Desilva; Thomas Abbruscato
Journal:  Int J Mol Sci       Date:  2012-10-03       Impact factor: 5.923

10.  Metabolic requirements for cancer cell proliferation.

Authors:  Mark A Keibler; Thomas M Wasylenko; Joanne K Kelleher; Othon Iliopoulos; Matthew G Vander Heiden; Gregory Stephanopoulos
Journal:  Cancer Metab       Date:  2016-08-18
View more
  11 in total

1.  Increased formation of reactive oxygen species during tumor growth: Ex vivo low-temperature EPR and in vivo bioluminescence analyses.

Authors:  Gang Cheng; Jing Pan; Radoslaw Podsiadly; Jacek Zielonka; Alexander M Garces; Luiz Gabriel Dias Duarte Machado; Brian Bennett; Donna McAllister; Michael B Dwinell; Ming You; Balaraman Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2019-12-23       Impact factor: 7.376

2.  MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma.

Authors:  Yiru Zhang; Trang T T Nguyen; Enyuan Shang; Angeliki Mela; Nelson Humala; Aayushi Mahajan; Junfei Zhao; Chang Shu; Consuelo Torrini; Maria J Sanchez-Quintero; Giulio Kleiner; Elena Bianchetti; Mike-Andrew Westhoff; Catarina M Quinzii; Georg Karpel-Massler; Jeffrey N Bruce; Peter Canoll; Markus D Siegelin
Journal:  Cancer Res       Date:  2019-11-06       Impact factor: 12.701

3.  Perillyl Alcohol Mitigates Behavioural Changes and Limits Cell Death and Mitochondrial Changes in Unilateral 6-OHDA Lesion Model of Parkinson's Disease Through Alleviation of Oxidative Stress.

Authors:  Ehraz Anis; Mohd Faraz Zafeer; Fakiha Firdaus; Shireen Naaz Islam; Azka Anees Khan; M Mobarak Hossain
Journal:  Neurotox Res       Date:  2020-05-11       Impact factor: 3.911

Review 4.  New Insights into the Efficacy of Aspalathin and Other Related Phytochemicals in Type 2 Diabetes-A Review.

Authors:  Christo J F Muller; Elizabeth Joubert; Nireshni Chellan; Yutaka Miura; Kazumi Yagasaki
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

5.  The Combination of Δ9-Tetrahydrocannabinol and Cannabidiol Suppresses Mitochondrial Respiration of Human Glioblastoma Cells via Downregulation of Specific Respiratory Chain Proteins.

Authors:  Anne Rupprecht; Ulrike Theisen; Franziska Wendt; Marcus Frank; Burkhard Hinz
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

6.  Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide.

Authors:  Nadja I Lorenz; Alina C M Sittig; Hans Urban; Anna-Luisa Luger; Anna L Engel; Christian Münch; Joachim P Steinbach; Michael W Ronellenfitsch
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

Review 7.  A Shifty Target: Tumor-Initiating Cells and Their Metabolism.

Authors:  Nicole Bezuidenhout; Maria Shoshan
Journal:  Int J Mol Sci       Date:  2019-10-28       Impact factor: 5.923

8.  Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells.

Authors:  Juan de Los Santos-Jiménez; José A Campos-Sandoval; Clara Márquez-Torres; Nieves Urbano-Polo; David Brøndegaard; Mercedes Martín-Rufián; Carolina Lobo; Ana Peñalver; María C Gómez-García; Janet Martín-Campos; Carolina Cardona; Laura Castilla; Felipe da Costa Souza; Tzuling Cheng; Juan A Segura; Francisco J Alonso; Rui Curi; Alison Colquhoun; Ralph J DeBerardinis; Javier Márquez; José M Matés
Journal:  J Biomed Sci       Date:  2021-02-20       Impact factor: 8.410

9.  The Nrf2/PGC1α Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer.

Authors:  Xinyue Deng; Nan Lin; Jiaying Fu; Long Xu; Haoge Luo; Yao Jin; Yanan Liu; Liankun Sun; Jing Su
Journal:  Oxid Med Cell Longev       Date:  2020-11-26       Impact factor: 7.310

Review 10.  The metabolomic landscape plays a critical role in glioma oncogenesis.

Authors:  Kenta Masui; Webster K Cavenee; Paul S Mischel; Noriyuki Shibata
Journal:  Cancer Sci       Date:  2022-03-23       Impact factor: 6.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.